A detailed history of Trifecta Capital Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 31 shares of BAX stock, worth $572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 31 -0.0%
Holding current value
$572
Previous $939,000 24.81%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025

BUY
$27.8 - $34.02 $861 - $1,054
31 New
31 $939,000
Q3 2023

Nov 01, 2023

SELL
$37.32 - $49.29 $821 - $1,084
-22 Reduced 55.0%
18 $680,000
Q1 2023

May 09, 2023

SELL
$37.58 - $52.57 $17,737 - $24,813
-472 Reduced 92.19%
40 $1.62 Million
Q4 2022

Jan 17, 2023

BUY
$49.7 - $57.71 $25,446 - $29,547
512 New
512 $26.1 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $9.31B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Trifecta Capital Advisors, LLC Portfolio

Follow Trifecta Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trifecta Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trifecta Capital Advisors, LLC with notifications on news.